BACKGROUND: Abdominal obesity is an important risk factor for the development of non-insulin dependent diabetes mellitus and other atherogenic disorders. The recently discovered fat-derived hormone leptin has been proposed to regulate adiposity through stimulation of satiety and increased energy expenditure. This study was undertaken to examine the relationship between fasting plasma leptin, body fat distribution and atherogenic complications in markedly obese adult subjects. SUBJECTS: The study comprised 29 women and 26 men who all were obese but otherwise healthy (body mass index, BMI, 33±60 kg/m 2 ). RESULTS: In 37 of the obese subjects, who were characterized in detail, the fasting plasma leptin levels correlated with plasma insulin (70.34) but not in a signi®cant way with blood pressure, insulin sensitivity, plasma glucose tolerance or circulating concentrations of glucose, lipoproteins, catecholamines or plasminogen activator inhibitor-1. In the whole patient material the fasting plasma leptin levels were two times higher in women than in men who had similar body mass index values (P`0.0001), In spite of the fact that all subjects were massively obese, the plasma leptin values correlated positively with BMI (r 0.39, P 0.004). On the other hand, there was a negative correlation between plasma leptin and waist-to-hip ratio (r 0.65, P 0.0001), which was independent of BMI. CONCLUSION: Except for a quite weak relationship with fasting plasma insulin, leptin appears not to be associated with classical metabolic atherogenic complications to obesity. Instead, it may protect obese subjects with a gynoid fat distribution from metabolic complications. About 40% of the variation in leptin in massively obese subjects could in fact be explained by peripheral fat distribution.
Introduction
It is well established that obesity is associated with diabetes and a number of metabolic and hormonal alterations which, in turn, may increase the risk of obese subjects to develop atherosclerotic diseases. These complications are most apparent in upperbody obese subjects who often have a cluster of complications, and where insulin resistance and/or hyperinsulinemia are believed to be of central importance. 1 The mechanisms behind the imbalance in energy intake and energy expenditure that are responsible for the development of obesity are less well understood. Although over-eating and physical inactivity are of importance, genetic and other intrinsic factors are also involved. 2 The recent identi®cation of the obese (ob) gene 3 and its corresponding protein leptin as well as its receptor 4 have been important steps in the understanding of the pathophysiology of obesity. Mutations in the genes coding for both these proteins can entirely explain the development of obesity in certain models of inbred rodents. 5 Furthermore, a number of studies have reported increased expression of leptin mRNA and circulating leptin in obese subjects as reviewed. 5 Leptin action has been intensively studied in animal models. 5 It is exclusively produced in adipose tissue from which it is secreted into the circulation and transported to the hypothalamic area where it is presumed to act as a lipostat mechanism through modulation of satiety signals and sympathetic nervous system mediated energy expenditure. The afferent loop from the brain back to adipose tissue may also involve glucocorticoids and insulin, at least in rodent models. 5 The role of leptin in man is unknown so far. Although it is possible that this protein is simply a marker for body weight, indirect evidence indicate a more active role. Thus, there are great interindividual variations in leptin mRNA 6±8 and in circulating leptin concentrations, 7, 8 both in normal-weight and obese subjects. A marked in¯uence of gender is present as well. Both the mRNA levels and the plasma concentrations of leptin are much higher in obese women than men.
6±8
It has previously been demonstrated in man, that leptin expression may be higher in subcutaneous adipose tissue than in the omental, retriperitoneal and mesenteric fat depots. 9 However, until presently little is known about the potential associations between leptin on the one hand and body fat distribution or complications to obesity, on the other hand. These questions were assessed in the present study by investigations of markedly obese male and female subjects that were remitted to the hospital for obesity surgery. They underwent a clinical and metabolic examination and the results were related to the individual fasting plasma leptin level.
Patients and methods

Patients
The complete study comprised 37 consecutive obese patients (21 were women) ageing 23±53 y, remitted to the hospital for obesity surgery. Body mass index (BMI, namely body weight divided by length in squares) ranged from 33±60 kg/m 2 . Four subjects had non-insulin dependent diabetes mellitus, two of them were treated with sulphponylurea while the other two only had dietary treatment. Six subjects had essential hypertension and received antihypertensive pharmacotherapy. In one of the subjects hypertension and received antihypertensive pharmacotherapy. In one of the subjects hypertension and diabetes coexisted. Two patients had mild asthma. Otherwise all subjects were healthy and on no medication. In addition 18 consecutive obese, otherwise healthy and drugfree, subjects (8 women) that had also been remitted to the hospital for obesity were included for the part of the study that concerned the relationship between leptin and body fat distribution. The BMI of the additional 18 patients ranged from 35± 53 kg/m 2 . All subjects were Caucasians and born in Sweden. The women were all premenopausal and examined in the middle of the follicular cycle. All subjects were sedentary or undertook moderate exercise not more than once per week. The study was approved by the Ethics Committee of the Karolinska Institute, Stockholm, Sweden. All patients gave informed consent to participate in the study.
Study protocol
The subjects came twice to the laboratory at 8 am after an overnight fast. On one occasion blood pressure was measured with a mercury sphygmomanometer on the right arm in supine position. Systolic and diastolic blood pressure values are the means of three consecutive measurements after a 10 min rest, using phases I and V of the Korotkoff sounds. The waist-to-hip ratio (WHR) was also measured in the supine position at the same occasion and was used as an indirect measure of body fat distribution. The waist was measured midway between the lower costae and the iliac crest, while the hip circumference was measured in the widest part of the hip region. The measurements were performed by the same nurse in all patients.
Venous blood samples for determination of metabolic laboratory parameters were obtained after the subjects had been resting in supine position for 15 min. They were all analyzed by the hospital's routine chemistry laboratory, except for circulating plasma insulin and leptin, which were measured with commercially available radioimmunoassay kits (Pharmacia-Upjohn, Uppsala, Sweden for insulin and Linco Research Inc. St Charles, MO for leptin). The leptin assay is completely homologous since the antibody was raised against highly puri®ed human leptin and both the standard and tracer are prepared with human leptin. The samples were run in duplicate. All samples were in the detection range of the kit, namely 0± 100 ng leptin/ml and the coef®cient of variance within the sample was 6%. Furthermore, on the ®rst visit, an oral glucose load (75 g) was performed and plasma glucose and insulin were measured at 0 and 120 min, respectively. On the second visit an intravenous insulin tolerance test was performed in the supine position after a 15 min rest as described previously. 9 In brief, crystalline human insulin (Actrapid R , Novo-Nordisk, Copenhagen, Denmark) was rapidly injected intravenously as a bolus dose (0.1 U/kg body weight). Venous blood was obtained from the contralateral antecubital vein at 0, 2, 4, 8, 10, 12, 14 and 16 min for the analysis of glucose and catecholamines at 0 and 12 min. A rate constant (Kitt) was derived from a semilogarithmic plot of the fall in blood glucose level. The best ®t was always obtained when time points from 4±16 min were used. Therefore these values were used to determine Kitt. Plasma catecholamine levels were almost identical at 0 and 12 min, indicating that the Kitt value was not in¯uenced by adrenergic counterregulation. As discussed, Kitt mirrors over-all insulin sensitivity and correlates strongly with insulin sensitivity measured by the hyperinsulinemic, euglycemic clamp technique. 10 
Statistical methods
Values are given as the mean AE standard deviation (s.d.). The Student's two-tailed unpaired t-test factor analysis, and simple, stepwise or multiple regression analysis were employed for statistical comparisons. Not more than four independent variables (n/10) were used in the two-way stepwise regression analysis. The variable with the highest partial correlation coef®cient was entered at each step until no variable remained with an F-value of four or more. All statistical calculations were performed with a statistical software package (STATVIEW II, Abacus Concepts Inc, Berkeley, CA).
Results
The data from the completely investigated subjects shown in Table 1 . As a group the subjects displayed a number of expected classical abnormalities associated with obesity, such as elevated blood pressure and increased plasma levels of leptin, insulin, triglycerides, plasminogen activator inhibitor-1 (PAI-1) and glucose, as well as low plasma HDL cholesterol, reduced insulin sensitivity (as determined by Kitt) and reduced oral glucose tolerance.
The different variables were compared by factor analysis. The correlation matrix is shown in Table 2 . A number of expected signi®cant correlations which often are associated with obesity were obtained, such as WHR on the one hand and PAI-1, Kitt, fasting insulin and diastolic blood pressure on the other hand. Fasting plasma leptin correlated signi®cantly only with gender, BMI, WHR, plasma insulin and insulin sensitivity.
The relationship between leptin and plasma insulin was further explored taking into consideration the in¯uence on leptin of BMI, WHR and sex by stepwise and multiple regression analysis. Leptin, WHR, BMI and sex were used together as independent variables. leptin did not contribute signi®cantly to the variations in plasma insulin, where WHR was the only independent regressor.
The relationships between BMI, WHR and leptin were also further examined. Because of the strong in¯uence of gender on these parameters, it was necessary to increase the material in order to improve statistical power as regards the importance of gender for BMI, WHR and leptin. The comparison of obese men and women are shown in Table 3 . As expected, WHR was lower in the female group than in the male group. However, in spite of similar age and BMI in the two groups, the plasma leptin levels were, on average, two times higher in obese women than in obese men.
The correlations between leptin on the one hand and BMI and WHR, respectively on the other hand, were examined in the complete patient material. The results of the linear regression analyses are shown in Figure 1 . leptin correlated positively with BMI (r 0.39, P 0.004) while there was a strong negative association with WHR (r 0.65, P 0.0001). In these massively obese subjects about 40% (namely adjusted r 2 ) of the variation in WHR, but only 13% of the variation in BMI, could be attributed to leptin. Men and women were also analyzed separately. Leptin showed a positive relationship with BMI both in men (r 0.55, P 0.0003) and women (r 0.41, P 0.003), and a signi®cant negative relationship with BMI in women (r 70.46, P 0.01) but not in men (r 0.23, P 0.25), data not shown.
The in¯uence of BMI and WHR on leptin was further investigated, in the whole patient material, using stepwise regression analysis. When BMI and WHR were used together as independent variables WHR (F 35.8), but not BMI (F 2.7), contributed in a signi®cant way to the variation in leptin. As waist circumference alone and waist/height ratio recently have been suggested to correlate more strongly with visceral fat than WHR we also tested these parameters versus circulating leptin in simple regression analyses. However, no relationships were observed nether when we investigated the complete patient material, nor when we examined men and women separately.
Discussion
The emerging interaction between leptin and body fat and the co-morbidity of upper-body obesity and a number of atherosclerosis promoting abnormalities have raised the question whether variations in leptin Leptin and obesity F Lo Ènnqvist et al Statistically signi®cant relationships (P`0.05) are marked in bold. All symbols are explained in Table 1 .
Leptin and obesity F Lo Ènnqvist et al may contribute to fat distribution and morbidity in the obese population. The present data indicate that leptin may play a protective role in the pathophysiology of obesity as it appears to be associated more with the peripheral fat depot than the visceral fat. Dyslipidemia, hypertension, insulin resistance, hyperinsulinemia, glucose tolerance and coagulation abnormalities are a cluster of atherogenic disorders which accompany obesity associated with abdominal fat accumulation. 1 In this study we found no evidence for important associates between fasting plasma leptin and these complications to obesity. However, it should be emphasized that we examined massively obese subjects and that there are more sophisticated techniques to assess in vivo insulin sensitivity than Kitt. On the other hand, the role of insulin in leptin regulation appears to be less prominent in humans than was initially believed from animal models. During the last year it has been demonstrated that the association of leptin and obesity is very similar in diabetic and non-diabetic nondiabetic subjects. 11 Furthermore, inshort time experiments, nether euglycemic hyperinsulinemia not a 5 d caloric restriction 12,13 altered the leptin levels, while both insulin, glucose and resting metabolic rate levels changed simultaneously in the latter situation. Although an diurnal rhythm in circulating leptin has been reported in both lean, obese and NIDDM subjects, no relationships between circulating leptin and insulin or glucose during the 24 h pro®les were observed.
14 However, after a 72 h long hyperglycaemic clamp a long term stimulatory effect of insulin on ob gene expression could be demonstrated. 15 Consequently, in short term, insulin does not appear to be related to leptin production in humans, while an indirect effect, probably through its trophic effects on adipocytes, could not be excluded in chronic hyperinsulinemia.
A number of studies have shown that leptin mRNA and plasma levels are increased in most obese subjects. 5±8 In agreement with these earlier, well-established, ®ndings we found a signi®cant relationship between BMI and plasma leptin also in the presently investigated, massively obese subjects in either sex. If leptin acts is the same way in man as it does in rodent models, leptin resistance may be involved in the development of obesity. One possible mechanism that may contribute to leptin resistance in man is an impaired transport of leptin over the blood brain barrier. In fact, it has recently been demonstrated that obese subjects have 4±5 times lower cerebrospinal¯uid/plasma leptin ratios compared to lean subjects. 16, 17 Alternatively, leptin resistance could also be due to a increased proportion of protein found versus free leptin in the circulation in obese as compared to lean subjects. However, this possibility remains to be investigated.
It is well established that women are more prone to develop adiposity than men. Con®rming earlier observations 6 we found much higher plasma leptin concentrations in obese women than in obese men, in spite of similar BMI. Since body fat was not determined we cannot exclude the possibility that gender differences in leptin at least in part could be due to a higher fat mass in the obese women. However, such factors cannot explain the strong negative relationship between leptin and body fat distribution (as determined by WHR). As much as 40% of the variation in body fat distribution could be attributed to leptin, an association that was more prominent in women, but was independent of BMI. The data suggest that leptin, through yet unknown mechanisms, is more important for the development of peripheral obesity than for visceral obesity. If so, leptin could play a protective role and prevent the development of diabetes and other atherogenic complications to obesity, since female fat distribution has no or little association with these complications in the obese populations. 1 Although little is known about the potential associations between leptin on the one hand and body fat distribution or complications to obesity it has previously been demonstrated that leptin expression is higher in subcutaneous than in visceral adipose tissue in man. 9 Furthermore, in animal studies, it has been shown that leptin treatment not only affect the total amount of body fat but also several endocrinological aberrations. For example, the sterility that accompanies obesity in female ob/ob mice can be corrected by treatment with leptin 18 and the starvation-induced changes in the gonadal, adrenal and thyroid axes in male mice and the delay in ovulation in female mice can be prevented with administration of exogenous leptin.
19 Therefore, it is fully possible that leptin may be involved in sex-hormone regulated regional fat distribution, and nutrient partitioning, also in man. Anyhow, this fat, there is no strong evidence for this hypothesis. It can not be excluded that it is instead the distribution of adipose tissue that affects the plasma leptin concentrations. Clearly, further prospective and epidemiological studies are needed to support the theory about a protective role of leptin in obesity.
The absence of a signi®cant relationship between peripheral fat distribution and leptin in obese men could be due to an insuf®cient number of male patients. In fact, in Figure 1 , the WHR values of the obese men are distributed along the same regression line as in obese women. On the other hand, it cannot be excluded that the discrepancy between men and women is instead a consequence of the gender speci®c differences in adipose tissue distribution. 1 It is, as yet, unknown if leptin in men is related to upper body fat accumulation. No correlations were found between waist leptin and the visceral fat depot may be less important. However, this question can only be answered by the use of more appropriate estimates of visceral fat, for example CT-scan evaluation.
When all data are considered together the present study argues strongly for that circulating leptin is not just a simple marker for fat mass in obesity, but may also be involved in the regulation of regional obesity and the development of peripheral, lower-body, obesity. The underlying mechanisms of action remains to be established. In this respect it is of interest to note that the leptin receipt is not only expressed in the brain but also in a number of periperhal tissues including adipose tissue. 20 Since a peripheral fat distribution is much less dangerous than a central distribution 1 it is tempting to suggest a protective role of leptin on obesity because of its association with peripheral fat distribution which is independent of BMI. This theory is further supported by the lack of an association between leptin and atherogenic abnormalities in obese subjects. Whether leptin is associated with a peripheral fat distribution also in non-obese or moderately obese subjects still remains to establish.
